Prashanth joined Brandon Capital in 2021.
Prashanth is based in Brandon’s Sydney-office and leads NSW activities for Brandon. Before joining Brandon, Prashanth was Senior Commercialisation Manager at UniSA Ventures, the commercialisation and investment-management arm of the University of South Australia (UniSA) where he led a series of complex licensing transactions and managed a portfolio of IP, and served as Operations Manager for AbRegen, which was an UniSA Ventures investee company.
Prashanth has been a part of several deal teams where he led diligence activities. Notable examples include investments into Pheon Therapeutics (Series A), and Advancell Isotopes.
Prashanth holds a B.Technology in Bioinformatics from Sathyabama University (India) and a PhD in Biochemistry and Molecular biology, and M. Biotech (Adv) from The University of Queensland.
